Skip to content

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00430664
Enrollment
100
Registered
2007-02-02
Start date
2006-01-31
Completion date
2007-12-31
Last updated
2007-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Pleural Effusions, Primary Spontaneous Pneumothorax, Recurrent Pleural Effusions, Secondary Spontaneous Pneumothorax

Keywords

pleurodesis, talc, iodopovidone

Brief summary

Pleurodesis is a technique used to fuse the two layers of the lining over the lung. This is done to get rid of collections of fluid or air in this space. A common reason would be cancer of the underlying lung or elsewhere causing fluid to collect in the pleural space. In this situation it is a palliative procedure to free the patient from symptoms like breathlessness.

Detailed description

Pleurodesis is a technique used to fuse the two layers of the pleura. This is done to prevent reaccumulation of collections of fluid or air in this space. Common indications are malignant pleural effusions, recurrent pneumothorax and even benign effusions which are otherwise difficult to eradicate.

Interventions

PROCEDUREPleurodesis with either talc or iodopovidone

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 12 years * Symptomatic recurrent pleural effusion * Pneumothorax needing pleurodesis

Exclusion criteria

* Life expectancy \<1 month * Unwilling to give consent * Empyema * ICTD drain output \>150 ml/d * Presence of an airleak

Design outcomes

Primary

MeasureTime frame
Success
Failure

Secondary

MeasureTime frame
Death
Pain by VAS
Time to Pleurodesis
Others

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026